NewAmsterdam Pharma Correlations
NAMSW Stock | 9.06 0.63 6.50% |
The current 90-days correlation between NewAmsterdam Pharma and NewAmsterdam Pharma is 0.66 (i.e., Poor diversification). The correlation of NewAmsterdam Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
NewAmsterdam Pharma Correlation With Market
Average diversification
The correlation between NewAmsterdam Pharma and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and DJI in the same portfolio, assuming nothing else is changed.
NewAmsterdam |
Moving together with NewAmsterdam Stock
0.66 | VTRS | Viatris | PairCorr |
0.67 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
0.65 | EWTX | Edgewise Therapeutics | PairCorr |
0.78 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
0.65 | EBS | Emergent Biosolutions | PairCorr |
0.79 | GILD | Gilead Sciences | PairCorr |
0.74 | MNMD | Mind Medicine | PairCorr |
0.74 | CPRX | Catalyst Pharmaceuticals | PairCorr |
Moving against NewAmsterdam Stock
0.87 | HLN | Haleon plc | PairCorr |
0.85 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.8 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.77 | ZTS | Zoetis Inc | PairCorr |
0.74 | LLY | Eli Lilly | PairCorr |
0.74 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.73 | TAK | Takeda Pharmaceutical | PairCorr |
0.7 | RDY | Dr Reddys Laboratories | PairCorr |
0.47 | LTRN | Lantern Pharma | PairCorr |
0.34 | ELAN | Elanco Animal Health | PairCorr |
0.69 | ANRO | Alto Neuroscience, | PairCorr |
0.62 | AMGN | Amgen Inc | PairCorr |
0.59 | ANEB | Anebulo Pharmaceuticals | PairCorr |
0.57 | ABBV | AbbVie Inc Sell-off Trend | PairCorr |
0.52 | TEVA | Teva Pharma Industries | PairCorr |
0.45 | CTLT | Catalent | PairCorr |
0.43 | SIGA | SIGA Technologies | PairCorr |
Related Correlations Analysis
0.3 | -0.75 | -0.11 | 0.8 | NAMS | ||
0.3 | 0.08 | 0.0 | 0.1 | SCLXW | ||
-0.75 | 0.08 | 0.31 | -0.77 | GRNAW | ||
-0.11 | 0.0 | 0.31 | -0.25 | OABIW | ||
0.8 | 0.1 | -0.77 | -0.25 | ROIVW | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between NewAmsterdam Stock performing well and NewAmsterdam Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NewAmsterdam Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NAMS | 2.35 | 0.07 | 0.06 | 0.16 | 3.39 | 5.33 | 29.23 | |||
SCLXW | 10.24 | 1.35 | 0.06 | (0.73) | 11.60 | 36.00 | 109.99 | |||
GRNAW | 12.98 | 0.31 | (0.01) | 0.00 | 14.82 | 32.45 | 85.19 | |||
OABIW | 7.32 | 0.43 | 0.00 | (0.07) | 8.05 | 21.43 | 56.83 | |||
ROIVW | 4.02 | 0.53 | 0.11 | 0.72 | 4.20 | 8.80 | 24.42 |
NewAmsterdam Pharma Corporate Management
Louise Kooij | Treasurer, CFO | Profile | |
Jim Jacobson | Chief Secretary | Profile | |
Annie Neild | VP Affairs | Profile | |
FESC MD | Chief Founder | Profile | |
Marc MD | Chief Officer | Profile | |
MSc MBA | Chief Officer | Profile | |
Lina Gugucheva | Chief Officer | Profile |